Extract from todays AFR:
"Fundie Q&A – Joanne Tran – Markets Reporter – Mar 7, 2024 – 2.00pm
Fidelity Fund manager Casey McLean names a biotech stock flying under the radar.
Casey McLean is portfolio manager of Fidelity’s Australian Opportunities Fund from Sydney. The firm oversees around $US776.2 billion ($1.18 trillion) globally.
What’s a stock you like that (most) people haven’t heard of?
PolyNovo is a burns treatment specialist. The product is lower cost, requires less hospital visits and has better efficacy and reduces the risk of infection compared to the incumbent animal-based solutions.
The product is approved in the US and the company is scaling up their sales force as they roll out to more hospitals driving strong sales growth. PolyNovo have also recently entered other large markets like India which are growing very quickly off a low base.
All of this means the company is growing revenue at 60 per cent with a long runway and has recently reached breakeven."
PNV Media Thread, page-3071
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.33 |
Change
-0.030(1.27%) |
Mkt cap ! $1.611B | |||
| Open | High | Low | Value | Volume |
| $2.34 | $2.37 | $2.32 | $1.213M | 518.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4869 | $2.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.34 | 16787 | 33 |
View Market Depth
| Last trade - 14.16pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.33 |
Change
-0.030 ( 1.24 %) |
||||
| Open | High | Low | Volume | ||
| $2.34 | $2.37 | $2.32 | 175472 | ||
| Last updated 14.35pm 14/06/2024 ? | |||||
| PNV (ASX) Chart |